Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

SUMATRIPTAN SUCCINATE

Closed
SPE2DP-26-T-4415Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
National Institutes Of Health Olao

POSTED

8 days ago

DEADLINE

in 7 days

AI Contract Overview

Show more

Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.

General Info

Mylan supplies 100 mg sumatriptan tablets, 9-count, FOB destination, for U.S. military use by Aug 4, 2026, per strict FDA and DLA specs.

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

UNIT 2497 CP 011 496 371 46 2418, APO, AE, 09094-3219, USA

Set-Aside

NONE

Documents

1

RFQ SPE2DP-26-T-4415 Request for Quotations

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
SUMATRIPTAN SUCCINATE TABLETS
SUMATRIPTAN SUCCINA
SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9 TABLETS. STORE AT 20
TO 25 C (68 TO 77 F). [SEE USP CONTROLLED ROOM TEMPERATURE.]PROTECT
FROM LIGHT. INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR
WITHOUT AURA IN ADULTS.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0013-09 MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-5632-59
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4415
SECTION B
PR: 7017693070 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017693070 0001 BT 1.000
NSN/MATERIAL:6505017278704
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5612
FM5612 86 MDSS SGSM
UNIT 2497 CP 011 496 371 46 2418
APO AE 09094-3219
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FM5612
FM5612 86 MDSS SGSM
UNIT 3219BLDG 2497 CP 0110114963714
LINCOLN BLVD RAMSTEIN FLUGPLATZ
RAMSTEIN 66877
DE
M/F: (TCN) FM561262110017
RDD:
PROJ: TP 3
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 13
SPE2DP-26-T-4415
SECTION B
PR: 7017693070 PRLI: 0001 CONT’D
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:08/04/2026
SPE2DP-26-T-4415 NSN/Part Number: 6505-01-727-8704 Quantity: 1 BT Purchase Request: 7017693070QTY: 1 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS